IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.270
EU - Europa 6.815
AS - Asia 4.006
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 15
SA - Sud America 6
OC - Oceania 3
Totale 19.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.041
CN - Cina 2.676
UA - Ucraina 1.468
IE - Irlanda 1.299
SG - Singapore 1.110
DE - Germania 1.023
FI - Finlandia 914
SE - Svezia 875
IT - Italia 837
CA - Canada 225
TR - Turchia 166
AT - Austria 127
GB - Regno Unito 97
FR - Francia 49
BE - Belgio 44
EU - Europa 19
IN - India 17
RO - Romania 17
NL - Olanda 14
ES - Italia 13
JP - Giappone 12
CZ - Repubblica Ceca 11
BR - Brasile 5
CI - Costa d'Avorio 5
HK - Hong Kong 5
ID - Indonesia 4
IL - Israele 4
EE - Estonia 3
EG - Egitto 3
IR - Iran 3
MX - Messico 3
NZ - Nuova Zelanda 3
PL - Polonia 3
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CH - Svizzera 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
GR - Grecia 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RW - Ruanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 19.134
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.542
Dublin 1.297
Chandler 1.006
Singapore 885
Dearborn 762
Beijing 744
Ashburn 484
Nanjing 483
Boardman 472
Princeton 365
Ann Arbor 286
San Mateo 285
Santa Clara 231
Wilmington 206
Toronto 202
Kunming 169
Bremen 167
Parma 162
Shenyang 154
Izmir 150
Hefei 149
Nanchang 138
Vienna 126
Hebei 118
New York 116
Des Moines 100
Shanghai 100
Jinan 88
Helsinki 75
Grafing 68
Jiaxing 62
Tianjin 54
Woodbridge 51
Changsha 49
Guangzhou 48
Norwalk 47
Seattle 44
Brussels 42
Düsseldorf 37
Fremont 34
Marseille 32
Hangzhou 28
Rome 28
Zhengzhou 27
Chengdu 24
Los Angeles 22
Milan 20
Fuzhou 19
Ningbo 17
Houston 16
Dallas 15
Haikou 13
Reggio Nell'emilia 13
Torino 13
Frankfurt am Main 12
Kocaeli 12
Modena 12
Munich 12
Taiyuan 12
Taizhou 12
Wenzhou 12
Wuhan 12
Nakano 11
Ottawa 11
Shaoxing 11
Auburn Hills 10
Florence 10
Redmond 10
Timisoara 10
Washington 10
Falls Church 9
Napoli 9
Redwood City 9
Verona 9
Palermo 8
Rockville 8
Borås 7
Catania 7
Chongqing 7
Xian 7
Bari 6
Bilbao 6
Bologna 6
London 6
Naples 6
Quzhou 6
Scottsdale 6
Turin 6
Abidjan 5
Baotou 5
Chaoyang 5
Edinburgh 5
Fairfield 5
Mestre 5
Pune 5
Rio Saliceto 5
Carpineti 4
Genova 4
Horia 4
Jakarta 4
Totale 12.248
Salva come PNG Salva come JPEG
Nome #
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 197
Cap. 6. Differenziamento reale e differenziamento temporaneo. 129
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 121
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 120
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 114
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 101
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 98
Metabolic profiling of Candida albicans 98
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 96
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 93
Antifungal peptides within the antibodies 93
Screening of thiosemicarbazones as antimycotic drugs 93
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 93
Antibodies as a source of anti-infective peptides: an update 91
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 90
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 89
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 88
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 87
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 86
Antibody peptide based antifungal immunotherapy 85
Antibody-mediated protective immunity in fungal infections 85
Fungicidal activity of peptides encoded by immunoglobulin genes 82
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 81
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 81
A synthetic peptide as a novel anticryptococcal agent 80
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 80
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 80
Anti-septic shock recombinant vaccine. 80
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 80
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 79
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 79
Peptides from the inside of the antibodies are active against infectious agents and tumours 79
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 78
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 78
Applicazioni della Biologia Molecolare in Micologia. 78
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 78
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 78
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 78
Natural and synthetic peptides with antifungal activity 78
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 77
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 77
Agenti virali di gastroenterite. 77
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 77
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 77
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 75
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 75
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 75
Antibodies as Crypts of Antiinfective and Antitumor Peptides 74
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 73
Wickerhamomyces yeast killer toxins’ medical applications 73
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 72
Antibiobodies: antibiotic internal image antibodies 72
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 72
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 72
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 71
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 70
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 70
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 70
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 70
Antifungal activity of the C-terminal peptide from human serum albumin 70
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 69
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 69
Anticorpi immagini interne di tossine killer 69
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 68
Spettro d'azione universale di mimotopi killer antifungini 68
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 68
Antireceptor yeast killer toxin-like antibiobodies 68
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 68
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 68
Metabolic profile of Candida albicans 68
Antibiobodies: antibiotic-like antiidiotypic antibodies. 68
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 67
Mode of action of a killer peptide against Toxoplasma gondii 67
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 66
A transphyletic anti-infectious control strategy based on the killer phenomenon. 66
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 66
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 65
L'automazione integrata nel Laboratorio di Batteriologia. 65
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 65
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 65
Indagini batteriologiche e virologiche su campioni di feci in pazienti affetti da gastroenterite acuta osservati presso gli Ospedali Riuniti di Parma. 64
Innate antimicrobial and antiviral activities of antibody peptides 64
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 64
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 64
Any antibody fragment might exert antifungal activity 64
Attività protettiva di anticorpi killer anti-idiotipo nell’aspergillosi polmonare invasiva in un modello murino di trapianto di midollo osseo allogenico privo di linfociti T. 64
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 63
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 63
Protective antifungal yeast killer toxin-like antibodies 62
Immunizzazione neonatale nei confronti dell'infezione da streptococco di gruppo B mediante vaccini antiidiotipici ricombinanti. 62
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 62
Candidacidal properties of peptides encoded by immunoglobulin genes 62
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 62
Les récepteurs des toxines killer de levure 61
Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods. 61
Automazione dell’antibiogramma diretto sulle urine. 61
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 61
Human natural yeast killer toxin-like antibodies 60
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 60
Restriction of Influenza virus multiplication induced by PK peptide treatment 60
Totale 7.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.306 0 0 0 0 0 495 572 119 373 317 105 325
2020/20212.308 10 323 310 25 337 27 325 21 480 46 352 52
2021/20221.638 27 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20251.718 48 415 404 285 412 154 0 0 0 0 0 0
Totale 19.293